在促进多发性骨髓瘤治疗方面,Selinexor的免疫调节作用
Kereshmeh Tasbihi1, Heiko Bruns1
1Department of Medicine 5-Hematology and Oncology, University Hospital Erlangen, 91054 Erlangen, Germany.
Cells
|March 26, 2025
概括
针对多发性骨髓瘤 (MM) 的新疗法Selinexor针对Exportin-1 (XPO1) 诱导癌细胞死亡. 本综述探讨了它对瘤微环境 (TME) 的免疫调节作用,以改善MM治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 多发性骨髓瘤 (MM) 是一种渐进的血细胞恶性瘤,具有抗药性和高复发率的挑战.
- 瘤微环境 (TME) 显著影响MM治疗的成功和疾病复发.
- 新型治疗策略对于改善复发性和耐药性MM患者的治疗结果至关重要.
研究的目的:
- 审查Selinexor对MM瘤微环境 (TME) 的免疫调节作用.
- 阐明Selinexor对TME内的免疫细胞相互作用的影响.
- 探索潜在的新型治疗点和MM的未来免疫治疗方案.
主要方法:
- 文献综述侧重于Selinexor的作用机制及其对TME的影响.
- 对Selinexor对出口素-1 (XPO1) 的选择性抑制及其对癌症相关蛋白的下游影响的分析.
- 研究Selinexor的免疫调节能力及其对TME内的免疫细胞网络的影响.
主要成果:
- 塞利尼克索选择性地抑制XPO1,破坏核细胞质运输并诱导髓瘤细胞的亡.
- 塞林克索对瘤细胞具有选择性细胞毒性.
- 目前正在研究Selinexor对TME的免疫调节作用,有可能影响免疫细胞相互作用.
结论:
- 塞利尼克索尔通过准XPO1并诱导癌细胞亡,为MM提供了一种新的治疗方法.
- 了解Selinexor对TME的免疫调节作用对于优化MM治疗策略至关重要.
- 对Selinexor对免疫细胞网络的影响的进一步研究可能会揭示MM中高级免疫瘤治疗的新标.
关键词:
在-1的出口中.这就是Selinexor.一个XPO1一个XPO1一个XPO1在XPOVIO中使用XPOVIO.免疫疗法 免疫疗法多发性骨髓瘤是多发性骨髓瘤的一种.核出口核出口的情况瘤微环境是一个微环境.更多相关视频
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.6K
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.3K
相关概念视频
Tumor Immunotherapy
450
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
450
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
119
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
119
